To include your compound in the COVID-19 Resource Center, submit it here.

FDA warns Canadian company for selling unapproved, misbranded drugs

As bipartisan support in Congress for importation grows, FDA warns that a Canadian company is selling unapproved and misbranded drugs to U.S. consumers.

FDA accused CanaRx

Read the full 255 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE